Search results
ASCO24: An early look at cancer drug study results
BioPharma Dive via Yahoo Finance· 13 hours agoOn one hand, Phase 2 trial findings for Merck’s TIGIT-targeting drug vibostolimab coformulated with Keytruda shrank or eliminated tumors in a larger...
Here's Why Merck (MRK) Stock Has Outperformed Industry YTD
Zacks via Yahoo Finance· 4 days agoMerck MRK boasts more than six blockbuster drugs in its portfolio, with PD-L1 inhibitor Keytruda...
AstraZeneca’s $80B sales plan leans on cancer drug expansion
BioPharma Dive via Yahoo Finance· 3 days agoOne of the drugs, the lung cancer treatment Tagrisso, has already exceeded $5 billion in annual...
Eisai Showcases Oncology Portfolio and Pipeline at ASCO 2024
FOX 23 News Albany· 18 hours agoEisai announced today the presentation of research across multiple types of cancer from its oncology portfolio and pipeline during the 2024 American Society of Clinical Oncology ...
Pharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates
Zacks via Yahoo Finance· 7 days agoMerck MRK will discontinue the Keytruda plus vibostolimab co-formulation arm of a phase III melanoma...
Why Merck (MRK) is a Top Momentum Stock for the Long-Term
Zacks via Yahoo Finance· 2 days agoKeytruda has played an instrumental role in driving Merck’s steady revenue growth in the past few...
Medicenna to Present Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming Sachs 10th Annual...
Digital Journal· 2 days agoMedicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQB: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines, announced today that it ...
Bargain Bin: 3 Cheap Stocks to Buy Before Memorial Day
InvestorPlace· 10 hours agoWall Street investors are looking for cheap stocks to buy before the summer holiday period. Despite...
Intravenous Immunoglobulin (IVIG) Therapy: How It Works and What to Expect
Verywell Health via Yahoo News· 3 days agoIntravenous Immunoglobulin (IVIG) therapy is a biologic treatment used for immunodeficiencies,...
